| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,898 |
9,511 |
$868K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,985 |
5,829 |
$393K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,607 |
4,383 |
$123K |
| 80050 |
General health panel |
2,425 |
2,381 |
$109K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
892 |
845 |
$100K |
| 80053 |
Comprehensive metabolic panel |
9,548 |
9,057 |
$100K |
| 80061 |
Lipid panel |
4,679 |
4,600 |
$66K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
347 |
344 |
$60K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,406 |
10,783 |
$59K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
637 |
579 |
$57K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,360 |
1,327 |
$50K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,084 |
1,066 |
$39K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,100 |
1,068 |
$36K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
368 |
357 |
$32K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,670 |
1,518 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,617 |
2,501 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
1,503 |
1,452 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,325 |
3,261 |
$22K |
| 70450 |
Computed tomography, head or brain; without contrast material |
312 |
301 |
$19K |
| 82607 |
|
1,702 |
1,673 |
$18K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
193 |
190 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
678 |
653 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,005 |
1,888 |
$16K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
262 |
260 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
202 |
183 |
$11K |
| 81001 |
|
4,036 |
3,866 |
$10K |
| 84702 |
|
600 |
443 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,021 |
912 |
$10K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
331 |
324 |
$10K |
| 82728 |
|
745 |
727 |
$9K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
367 |
356 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
288 |
279 |
$7K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
34 |
34 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
570 |
511 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
273 |
264 |
$7K |
| 84484 |
|
698 |
650 |
$6K |
| 84439 |
|
714 |
698 |
$6K |
| 83540 |
|
649 |
632 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
651 |
622 |
$5K |
| 86803 |
|
256 |
250 |
$5K |
| 85027 |
|
698 |
625 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
190 |
181 |
$4K |
| 76830 |
Ultrasound, transvaginal |
75 |
73 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
175 |
169 |
$4K |
| 83690 |
|
799 |
764 |
$4K |
| 76642 |
|
83 |
80 |
$4K |
| 83735 |
|
539 |
493 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,596 |
1,472 |
$3K |
| 83550 |
|
611 |
599 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
353 |
344 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
46 |
42 |
$3K |
| 82570 |
|
315 |
299 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
325 |
314 |
$2K |
| 84703 |
|
202 |
199 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
211 |
204 |
$2K |
| 81025 |
|
563 |
531 |
$2K |
| 82043 |
|
216 |
210 |
$2K |
| 93971 |
|
31 |
31 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
26 |
26 |
$2K |
| 94726 |
|
54 |
51 |
$1K |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
31 |
28 |
$1K |
| 94729 |
|
40 |
37 |
$1K |
| 97597 |
|
58 |
30 |
$1K |
| 80081 |
|
14 |
13 |
$1K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
52 |
51 |
$997.82 |
| 87340 |
|
64 |
61 |
$910.37 |
| 82746 |
|
109 |
104 |
$901.88 |
| 76857 |
|
43 |
43 |
$854.90 |
| 85652 |
|
262 |
247 |
$828.16 |
| T1015 |
Clinic visit/encounter, all-inclusive |
16 |
15 |
$819.26 |
| 73630 |
|
84 |
75 |
$806.21 |
| 85610 |
|
240 |
215 |
$793.41 |
| 86850 |
|
106 |
102 |
$735.14 |
| 86140 |
|
214 |
199 |
$678.24 |
| 86901 |
|
161 |
154 |
$617.80 |
| 86900 |
|
162 |
155 |
$610.30 |
| 87150 |
|
13 |
13 |
$573.10 |
| 86592 |
|
132 |
127 |
$561.97 |
| 87186 |
|
75 |
71 |
$552.59 |
| 87077 |
|
77 |
75 |
$537.98 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,813 |
3,457 |
$536.40 |
| 85379 |
|
43 |
40 |
$455.98 |
| J3490 |
Unclassified drugs |
518 |
412 |
$436.69 |
| 87522 |
Neg quan hep c or qual rna |
13 |
12 |
$404.45 |
| 94060 |
|
40 |
37 |
$352.26 |
| 83605 |
|
52 |
49 |
$346.52 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
12 |
$309.00 |
| J2704 |
Injection, propofol, 10 mg |
510 |
398 |
$300.50 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
27 |
26 |
$296.80 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
261 |
238 |
$273.02 |
| 85730 |
|
30 |
30 |
$189.01 |
| 87081 |
|
30 |
30 |
$183.09 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,384 |
2,100 |
$182.62 |
| 74018 |
|
12 |
12 |
$151.15 |
| 81003 |
|
46 |
45 |
$140.07 |
| 80076 |
|
13 |
12 |
$136.02 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
528 |
469 |
$115.45 |
| 84156 |
|
35 |
27 |
$114.40 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
321 |
246 |
$97.14 |
| 99000 |
|
16 |
16 |
$96.00 |
| 82565 |
|
12 |
12 |
$90.13 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
789 |
708 |
$79.35 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
419 |
386 |
$77.32 |
| 84520 |
|
12 |
12 |
$76.50 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
17 |
14 |
$75.45 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
38 |
26 |
$17.82 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
296 |
254 |
$10.15 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
693 |
665 |
$4.80 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
13 |
13 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
39 |
37 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
82 |
65 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
94 |
79 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
34 |
33 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
17 |
12 |
$0.00 |